Table 3.
Maternal symptoms, biochemical markers, and adverse perinatal outcome
| Symptoms | Adverse perinatal outcome Present (n = 139) |
Adverse perinatal outcome Absent (n = 184) |
OR (95 % CI) | P value |
|---|---|---|---|---|
| Headache (n = 62) | 40 (64.51) | 22 (35.48) | 2.97 (1.67–5.29) | 0.002 |
| Visual disturbances (n = 29) | 24 (82.75) | 5 (17.24) | 7.4 (2.77–20.11) | 0.0001 |
| Right upper quadrant or epigastric pain (n = 38) | 28 (73.68) | 10 (26.31) | 4.3 (2.05–9.38) | 0.0001 |
| Chest pain or dyspnea (n = 40) | 25 (62.5) | 15 (37.5) | 2.47 (1.24–4.89) | 0.009 |
| Biochemical markers | Adverse fetal outcome Present n (%) |
Adverse fetal outcome Absent n (%) |
OR (95 % CI) | P value |
|---|---|---|---|---|
| Platelet count (<1.5 lacs) (n = 80) | 44 (55.0) | 36 (45) | 1.89 (1.13–3.15) | 0.014 |
| AST (>40 U/l) (n = 122) | 58 (47.54) | 64 (52.45) | 1.33 (0.84–2.09) | 0.21 |
| Serum creatinine (>1.1 mg/dl) (n = 77) | 43 (55.84) | 34 (44.15) | 1.96 (1.1–3.29) | 0.01 |
| Serum uric acid (>6 mg/dl) (n = 56) | 29 (51.78) | 27 (48.21) | 1.5 (0.85–2.7) | 0.15 |
| Dipstick proteinuria (≥2) | 58 | 29 | 3.8 (2.2–6.4) | <0.0001 |